Life Science Cares Launches in Switzerland
April 19 2024 - 11:12AM
UK Regulatory
Life Science Cares Launches in Switzerland
First international chapter of Life Science Cares
established in Switzerland – bringing hearts and minds together by
empowering the life sciences industry to support local
communities
ZURICH, Switzerland, April 19, 2024 (GLOBE NEWSWIRE) -- Today,
Life Science Cares, a collective effort of the life science
industry to reduce the impact of poverty and inequality in their
communities, launched in Switzerland, marking its first expansion
as an independent association into geographies outside of the
United States.
“We are excited to launch Life Science Cares Switzerland (LSCS)
today, in time, to engage with the local community at the upcoming
Swiss Biotech Day in Basel,” said Nadine Zahnd, Managing Director
of LSCS. “At the heart of our life sciences community is the
overwhelming sense to act and do good. We are building bridges
between Swiss Life Science Organizations and local charitable
organizations for individuals who may otherwise fail to access the
opportunities afforded to so many of us.”
In Switzerland in 2021, 1.24 million people, including many
families are considered at the brink of poverty. Those affected are
at risk of losing their social contacts and often suffer from
psychological and physical health problems. Children in such
families face often insurmountable obstacle to reach their full
potential. It is the mission of LSCS to break this cycle and offer
a path to unlock opportunity.
At the Swiss Biotech Day, LSCS will be showcased in the Plenary
Session on 22 April 2024 and in a dedicated Panel discussion
featuring the Swiss Red Cross, Cooley LLP, Novartis, the Swiss
Biotech Association (SBA) and Molecular Partners at 4.30 pm at
Marriott Hotel in Basel. Information will be available for everyone
who wishes to contribute to our mission at the SBA Booth.
The Board of LSCS will be constituted by Isabel Dalli, Novartis;
Sarah MacDonald, CEO LSC, Inc.; Dorothea Bergler, Swiss Red Cross;
Patrick Amstutz, Swiss Biotech Association / Molecular Partners;
Dieter Gericke, Homburger; Christoph Schmidt, up&up
communication.
Founding Members include Ulf Grawunder, Founder and former CEO
of NBE Therapeutics; Bill Burns, former CEO of Roche
Pharmaceuticals; Dominik Höchli, former Head of Global Medical
Affairs at Abbvie; Patrick Amstutz, CEO of Molecular Partners and
Chairman of Swiss Biotech Association, as well as Molecular
Partners, OM Pharma, the Swiss Biotech Association, HBM Healthcare
Investments and others.
About Life Science Cares Switzerland:
Life Science Cares Switzerland brings together the life science
community and local non-profit organizations to build bridges for
people with limited opportunities in our country. Our goal is to
provide access to education and opportunity for all who wish to
develop beyond their own limitations – by connecting the talents
and minds of the life science community with the hearts of
non-profit organizations. Learn more at www.lifesciencecares.ch
Contact:
Life Science Cares Switzerland
Nadine Zahnd-Straumann
Scheuchzerstrasse 35
CH-8006 Zürich
info@lifesciencecares.ch
www.lifesciencecares.ch
Molecular Partners (LSE:0QXX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Molecular Partners (LSE:0QXX)
Historical Stock Chart
From Jan 2024 to Jan 2025
